Projektnummer
N000390
Zusammenfassung
Neurodegeneration in childhood comprise a heterogeneous group ofdiseases that result from specific genetic and biochemical defects,chronic infections or inflammatory processes. The treatment ofneurodegenerative relies on the delivery of drugs to the brainparenchyma and it is constrained by the presence of the Blood-BrainBarrier (BBB) and the Brain-Cerebrospinal Fluid Barrier (BCSFB). Thepresent project will investigate for the first time an innovativenanotechnology platform of polymeric nanoparticles surface-modifiedwith folate receptor alpha (FRa), a glycosylphosphatidylinositol(GPI)-anchored...
Projektinformationen
Status:
Beendet
Startdatum:
01.01.2015
Enddatum:
31.12.2017
Fördersumme:
300.000 €
Profilbereich:
zukunft.niedersachsen
Förderinitiative:
Forschungskooperation Niedersachsen-Israel
Ausschreibung:
Forschungskooperation Niedersachsen - Israel (bis 2024)